Literature DB >> 8742432

Molecular single-cell analysis identifies somatostatin type 1 (sst1) receptors to block inwardly rectifying K+ channels in rat brain oligodendrocytes.

A Karschin1.   

Abstract

For the first time whole-cell patch-clamp recordings were performed together with a molecular analysis of mRNA expression on single rat cortical oligodendrocytes. The neuropeptide somatostatin (3 microM) was found to rapidly (< 1s) induce a 58 +/- 33% block of the inwardly rectifying K+ current (IKIR). Following recording, the cells' cytoplasm was harvested through the patch pipette and processed for RNA amplification. Polymerase chain reactions on the amplified products showed that of the primers specific for all five somatostatin receptor subtypes (sst1-sst5), only those derived from sst1 amplified cDNA fragments. Sequence analysis of these fragments revealed complete identity to rat sst1 receptors; thus they are probably the major subtype of somatostatin receptors that control IKIR in rat brain oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8742432

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  IRK(1-3) and GIRK(1-4) inwardly rectifying K+ channel mRNAs are differentially expressed in the adult rat brain.

Authors:  C Karschin; E Dissmann; W Stühmer; A Karschin
Journal:  J Neurosci       Date:  1996-06-01       Impact factor: 6.167

2.  Anxiolytic-like effects of somatostatin isoforms SST 14 and SST 28 in two animal models (Rattus norvegicus) after intra-amygdalar and intra-septal microinfusions.

Authors:  Michelle Yeung; Elif Engin; Dallas Treit
Journal:  Psychopharmacology (Berl)       Date:  2011-03-19       Impact factor: 4.530

3.  G protein-gated inwardly rectifying potassium channel subunits 1 and 2 are down-regulated in rat dorsal root ganglion neurons and spinal cord after peripheral axotomy.

Authors:  Chuang Lyu; Jan Mulder; Swapnali Barde; Kristoffer Sahlholm; Hugo Zeberg; Johanna Nilsson; Peter Århem; Tomas Hökfelt; Kaj Fried; Tie-Jun Sten Shi
Journal:  Mol Pain       Date:  2015-07-22       Impact factor: 3.395

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.